Haemonetics Corp
HAE· NYSE
HAEHaemonetics Corp
Filed May 20, 2024 · 10-K · 51 days after period end · 0000313143-24-000020
derived · Computed from the longer spans the company filed.
| Metric | Q4 2024dderived from reported figures | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures | Q4 2021 |
|---|---|---|---|---|
| Revenue | $343.29M | $304.42M | $265.00M | $225.03M |
| Net Income | $20.37M | $29.38M | $9.74M | -$11.04M |
| EPS Diluted | — | — |
Haemonetics Corp · CIK 313143 · Engraved from SEC EDGAR
| — |
| -$0.22 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ended Mar 30, 2024 · filed May 20, 2024 · 51 d after period end
